Filing Details

Accession Number:
0001209191-22-005748
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-01-31 18:47:33
Reporting Period:
2022-01-31
Accepted Time:
2022-01-31 18:47:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1290149 Sierra Oncology Inc. SRRA Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1551965 Gaurav Aggarwal C/O Sierra Oncology, Inc.
1820 Gateway Drive, Suite 110
San Mateo CA 94404
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-01-31 800,000 $27.00 2,735,853 No 4 P Indirect By Vivo Opportunity Fund, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Vivo Opportunity Fund, L.P.
Footnotes
  1. The Reporting Person is a managing member of Vivo Opportunity, LLC, which is the general partner of Vivo Opportunity Fund, L.P. The Reporting Person may be deemed to share voting and dispositive power over the securities held by Vivo Opportunity Fund, L.P. with four other managing members of Vivo Opportunity, LLC. The Reporting Person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.